A large body of evidence has supported that systemic phosphorylation and stimulation of NF-κB prevents tumor cell death and forms drug resistance induced by various conventional chemotherapeutics [11–14] and is thus associated with an unfavorable prognosis of tumor recovery. Here, NFKB1 is linked to neoplasm.